Section Arrow
Quote
AUTL.NASDAQ
- Autolus Therapeutics plc
Quotes are at least 15-min delayed:2026/04/09 04:21 EDT
Pre Market
Last
 1.45
-0.04 (-2.68%)
Bid
1.42
Ask
1.55
High 1.46 
Low 1.45 
Volume 1.01K 
Regular Hours (Closed)
Last
 1.49
+0.13 (+9.56%)
Day High 
1.5 
Prev. Close
1.36 
1-M High
1.695 
Volume 
1.82M 
Bid
1.42
Ask
1.55
Day Low
1.41 
Open
1.445 
1-M Low
1.175 
Market Cap 
361.95M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.33 
20-SMA 1.4 
50-SMA 1.48 
52-W High 2.7 
52-W Low 1.15 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.08/-0.94
Enterprise Value
428.78M
Balance Sheet
Book Value Per Share
0.67
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
75.39M
Operating Revenue Per Share
0.02
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.1831+0.0201+12.33%-- 
Pre Market 0.1868 +0.0037 +2.02%
VRAXVirax Biolabs Group Limited0.15+0.01+7.14%-- 
Pre Market 0.1477 -0.0023 -1.53%
ELABPmgc Holdings Inc4.5+1.05+30.43%0PE
Pre Market 4.3005 -0.1995 -4.43%
CUECue Biopharma0.2738+0.0856+45.48%-- 
Pre Market 0.22 -0.0538 -19.65%
GERNGeron Corp1.71-0.03-1.72%-- 
Pre Market 1.7 -0.01 -0.58%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3,AUTO5, AUTO6, AUTO7 & AUTO8.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.